Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients

By Carles Joan   Domenech Montserrat   Gelabert-Mas Antonio   Nogue Miquel   Tabernero Josep M.   Arcusa Angeles   Guasch Inmaculada   Miguel Ana   Ballesteros Juan J.   Fabregat Xavier  

Acta Oncologica, Vol. 37, Iss. 2, 1998-05 ,pp. : 187-191

Informa Healthcare

Access to resources Recommend Favorite

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer

By Hoshi Senji   Yamaguchi Osamu   Fujioka Tomoaki   Arai Yoichi   Tomita Yoshihiko   Habuchi Tomonori   Ohyama Chikara   Suzuki Tadashi   Orikasa Seiichi  

International Journal of Clinical Oncology, Vol. 11, Iss. 4, 2006-08 ,pp. : 303-308

Springer Publishing Company

Access to resources Recommend Favorite

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer

By Hoshi Senji   Yamaguchi Osamu   Fujioka Tomoaki   Arai Yoichi   Tomita Yoshihiko   Habuchi Tomonori   Ohyama Chikara   Suzuki Tadashi   Orikasa Seiichi  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 492-493

Springer Publishing Company

Access to resources Recommend Favorite

Management Strategies for Hormone-Refractory Prostate Cancer

By Attard Gerhardt   de Bono Johann S.   Parker Christopher C.   Horwich Alan  

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite

Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)

By Cho D.   Di Blasio C.J.   Rhee A.C.   Kattan M.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 282-291

Elsevier

Access to resources Recommend Favorite